A Study of Pomadomide in Combination With Rituximab and Methotrexate for Newly-diagnosed Primary Central Nervous System Lymphoma

NCT06554561 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

43

Enrollment

OTHER

Sponsor class

Conditions

PCNSL

Interventions

DRUG: Pomalidomide
DRUG: Rituximab
DRUG: Methotrexate

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University